304 results on '"RENAL cancer"'
Search Results
2. Kidney Cancer: Localized: Surgical Therapy V (MP67).
3. Kidney Cancer: Basic Research & Pathophysiology II (PD51).
4. Kidney Cancer: Localized: Surgical Therapy IV (MP56).
5. Kidney Cancer: Epidemiology & Evaluation/Staging/Surveillance II (MP51).
6. Kidney Cancer: Localized: Surgical Therapy II (PD33).
7. Kidney Cancer: Advanced (Including Drug Therapy) II (PD18).
8. Kidney Cancer: Advanced (including Drug Therapy) I (MP10).
9. A Comparison of Percutaneous Ablation Therapy to Partial Nephrectomy for cT1a Renal Cancers: Results from the Canadian Kidney Cancer Information System.
10. Familial Risk of Renal Cell Cancer and Interaction with Obesity and Hyperglycemia: A Population-Based Study.
11. Computer-Generated R.E.N.A.L. Nephrometry Scores Yield Comparable Predictive Results to Those of Human-Expert Scores in Predicting Oncologic and Perioperative Outcomes.
12. PD58-07 THE ROLE OF EXERCISE ON PHYSICAL AND MENTAL HEALTH IN KIDNEY CANCER.
13. PD58-06 PATIENTS' VALUES AND PREFERENCES FOR TREATMENT OF SMALL RENAL MASSES.
14. MP67-16 PREOPERATIVE ESTIMATION MODEL FOR PATHOLOGICAL T3 UPSTAGING IN PATIENTS WITH CLINICAL T1-2 CLEAR CELL RENAL CELL CARCINOMA UNDERWENT SURGERY: ANALYSIS FROM THE INTERNATIONAL MARKER CONSORTIUM FOR RENAL CANCER (INMARC).
15. PD51-07 REGULATION OF GLUTAMINE METABOLISM RESENSITIZES TKI-RESISTANT RENAL CANCER CELLS TO TKIS.
16. MP61-01 EXPLORING THE GENETIC LANDSCAPE OF SOMATIC VARIANTS IN PENILE CANCER PATIENTS.
17. MP56-16 MULTIPLE RENAL TUMORECTOMIES: A MATCHED COMPARATIVE ANALYSIS OF ROBOTIC AND OPEN APPROACHES (UROCCR STUDY N°60).
18. MP56-15 CLINICAL CHARACTERISTICS OF PATIENTS WITH RENAL CANCER DO IMPACT MORE THAN ISCHEMIA TIME ON POST-OPERATIVE RENAL FUNCTION.
19. MP51-17 NATURAL HISTORY OF PATIENTS WITH REGIONAL LYMPH NODE POSITIVE RENAL CELL CARCINOMA: RESULTS FROM THE CANADIAN KIDNEY CANCER COLLABORATION.
20. MP51-12 KIDNEY CANCER INCIDENCE IN CALIFORNIA: TEMPORAL TRENDS AND SOCIODEMOGRAPHIC PATTERNS FROM 1988 THROUGH 2019.
21. PD23-11 IMMUNE CHECKPOINT INHIBITORS FOR KIDNEY AND BLADDER CANCER: ADRENOTOXIC CONSEQUENCES.
22. MP30-16 HIGH-RESOLUTION ULTRASOUND: PILOT STUDY FOR HISTOLOGICAL SUBTYPES PATTERN CHARACTERIZATION IN KIDNEY CANCER.
23. PD20-10 COMPARISON OF NEOADJUVANT AND ADJUVANT CHEMOTHERAPY FOR UPPER TRACT UROTHELIAL CARCINOMA IN REAL-WORLD PRACTICE: A MULTICENTER RETROSPECTIVE STUDY.
24. PD18-11 DELAYED PARTIAL NEPHRECTOMY FOLLOWING COMPLETE RESPONSE TO IMMUNOTHERAPY: FEASIBILITY AND RESULTS (UROCCR N°157).
25. PD16-11 THE IMPACT OF INTEGRINS ON SELF-RENEWAL AND DIFFERENTIATION OF CANCER STEM CELLS IN WILMS TUMOR.
26. PD11-04 RELATIONSHIP BETWEEN SURGEON VOLUME AND POSTOPERATIVE BLEEDING FOR PARTIAL NEPHRECTOMY.
27. PD11-01 TRENDS AND COSTS OF MINIMALLY INVASIVE RENAL SURGERY FOR KIDNEY CANCER: A NATIONAL POPULATION-BASED STUDY.
28. MP10-20 ADJUVANT TARGETED DRUG THERAPY IN PREVENTING RECURRENCE OF HIGH-RISK RENAL CANCER POST-SURGERY: A SYSTEMIC REVIEW AND META ANALYSIS.
29. MP10-11 A PROPENSITY SCORE-MATCHED ANALYSIS OF OUTCOMES OF NEOADJUVANT AND ADJUVANT SYSTEMIC THERAPY IN HIGH-RISK LOCALIZED RENAL CELL CARCINOMA: IMPACT OF TIMING OF THERAPY AND POSITIVE MARGIN.
30. PD04-11 SURVIVORSHIP AFTER KIDNEY CANCER IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS – WHAT IS CAUSING DEATH AND WHEN?
31. Reviewer of the Month.
32. Uro-Science.
33. Reviewer of the Month.
34. Risk of Radiation from Computerized Tomography Urography in the Evaluation of Asymptomatic Microscopic Hematuria.
35. The Temporal Association of Robotic Surgical Diffusion with Overtreatment of the Small Renal Mass.
36. Can a Modified Bosniak Classification System Risk Stratify Pediatric Cystic Renal Masses?
37. Growth Kinetics of Small Renal Masses on Active Surveillance: Variability and Results from the DISSRM Registry.
38. External Validation of Contact Surface Area as a Predictor of Postoperative Renal Function in Patients Undergoing Partial Nephrectomy.
39. A Comparison of Percutaneous Ablation Therapy to Partial Nephrectomy for cT1a Renal Cancers: Results From the Canadian Kidney Cancer Information System. Reply.
40. A Comparison of Percutaneous Ablation Therapy to Partial Nephrectomy for cT1a Renal Cancers: Results From the Canadian Kidney Cancer Information System. Letter.
41. Renal Mass and Localized Renal Cancer: AUA Guideline.
42. Patient Function and the Value of Surgical Care for Kidney Cancer.
43. Re: Demographic Factors Associated with Non-Guideline-Based Treatment of Kidney Cancer in the United States.
44. A Comparison of Percutaneous Ablation Therapy to Partial Nephrectomy for cT1a Renal Cancers: Results from the Canadian Kidney Cancer Information System: EDITORIAL COMMENT.
45. Proteinuria is a Predictor of Renal Functional Decline in Patients with Kidney Cancer.
46. Expression of Genes Involved in Cellular Adhesion and Extracellular Matrix Remodeling Correlates with Poor Survival of Patients with Renal Cancer.
47. Impact of Reduced Glomerular Filtration Rate and Proteinuria on Overall Survival of Patients with Renal Cancer.
48. Risk of a Second Kidney Carcinoma Following Childhood Cancer: Role of Chemotherapy and Radiation Dose to Kidneys.
49. Re: Inactivation of the PBRM1 Tumor Suppressor Gene Amplifies the HIF-Response in VHL-/- Clear Cell Renal Carcinoma.
50. Long-Term Survival Rates after Resection for Locally Advanced Kidney Cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 Experience.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.